These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2530315)

  • 1. Lack of GTP-insensitive D2 dopamine receptors in Huntington's disease.
    De Keyser J; Roos RA; Ebinger G; Vauquelin G
    J Neurol Sci; 1989 Sep; 92(2-3):329-35. PubMed ID: 2530315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupling of D1 dopamine receptors to the guanine nucleotide binding protein Gs is deficient in Huntington's disease.
    De Keyser J; De Backer JP; Ebinger G; Vauquelin G
    Brain Res; 1989 Sep; 496(1-2):327-30. PubMed ID: 2529949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 dopamine receptors in calf globus pallidus: agonist high- and low-affinity sites not regulated by guanine nucleotide.
    De Keyser J; De Backer JP; Convents A; Ebinger G; Vauquelin G
    J Neurochem; 1985 Sep; 45(3):977-9. PubMed ID: 2411862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous dopamine receptor changes in early and late Huntington's disease.
    Richfield EK; O'Brien CF; Eskin T; Shoulson I
    Neurosci Lett; 1991 Oct; 132(1):121-6. PubMed ID: 1838580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN; Lexow N; Bird E; Winokur A
    Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2 dopamine receptors in the human brain: heterogeneity based on differences in guanine nucleotide effect on agonist binding, and their presence on corticostriatal nerve terminals.
    De Keyser J; Walraevens H; De Backer JP; Ebinger G; Vauquelin G
    Brain Res; 1989 Apr; 484(1-2):36-42. PubMed ID: 2523750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D-1 and D-2 receptors in Huntington's disease.
    Cross A; Rossor M
    Eur J Pharmacol; 1983 Mar; 88(2-3):223-9. PubMed ID: 6221936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In human brain two subtypes of D1 dopamine receptors can be distinguished on the basis of differences in guanine nucleotide effect on agonist binding.
    De Keyser J; Walraevens H; Ebinger G; Vauquelin G
    J Neurochem; 1989 Oct; 53(4):1096-102. PubMed ID: 2527968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.
    Richfield EK; Herkenham M
    Ann Neurol; 1994 Oct; 36(4):577-84. PubMed ID: 7944290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
    Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional distribution of monoamines and dopamine D1- and D2-receptors in the striatum of the rat.
    Russell VA; Allin R; Lamm MC; Taljaard JJ
    Neurochem Res; 1992 Apr; 17(4):387-95. PubMed ID: 1387462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone.
    Hägglund J; Aquilonius SM; Eckernäs SA; Hartvig P; Lundquist H; Gullberg P; Långström B
    Acta Neurol Scand; 1987 Feb; 75(2):87-94. PubMed ID: 2953165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors.
    Lévesque D; Di Paolo T
    Biochem Pharmacol; 1993 Feb; 45(3):723-33. PubMed ID: 8095140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in dopaminergic receptors in Huntington's disease.
    Reisine TD; Fields JZ; Stern LZ; Johnson PC; Bird ED; Yamamura HI
    Life Sci; 1977 Oct; 21(8):1123-8. PubMed ID: 144230
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
    Beckstead RM; Wooten GF; Trugman JM
    J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease.
    Weeks RA; Piccini P; Harding AE; Brooks DJ
    Ann Neurol; 1996 Jul; 40(1):49-54. PubMed ID: 8687191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1985 Mar; 109(3):417-9. PubMed ID: 3157589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.
    Richfield EK; Penney JB; Young AB
    Neuroscience; 1989; 30(3):767-77. PubMed ID: 2528080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidus.
    Seeman P; Wilson A; Gmeiner P; Kapur S
    Synapse; 2006 Sep; 60(3):205-11. PubMed ID: 16739118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.